Phytochem Remedies (India)
No trades in 1Y
Key Insights
Strengths
1- Company has a good return on equity (ROE) track record: 3 Years ROE 31.3%
No weaknesses listed
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024.
Revenue
| 3Y | +38.03% |
|---|---|
| 1Y | +11.60% |
Net profit
| 3Y | +103.70% |
|---|---|
| 1Y | +93.94% |
Operating cash flow
| 3Y | +36.06% |
|---|---|
| 1Y | Tiny base |
Operating margin· change in pp
| 3Y | +16.62 pp |
|---|---|
| 1Y | +5.87 pp |
Trailing twelve months: No quarterly results are reported.
Revenue by year
| Mar 2022 | ₹13.86 Cr |
|---|---|
| Mar 2023 | ₹20.82 Cr |
| Mar 2024 | ₹32.66 Cr |
| Mar 2025 | ₹36.45 Cr |
Net profit by year
| Mar 2022 | ₹0.53 Cr |
|---|---|
| Mar 2023 | ₹0.82 Cr |
| Mar 2024 | ₹2.31 Cr |
| Mar 2025 | ₹4.48 Cr |
Profit & Loss
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | 13.86 | 20.82 | 32.66 | 36.45 |
| Expenses | 12.86 | 17.91 | 26.79 | 27.76 |
| Operating Profit | 1 | 2.91 | 5.87 | 8.69 |
| OPM % | 7.22% | 13.98% | 17.97% | 23.84% |
| Other Income | 0.07 | 0 | 0.07 | 0.27 |
| Interest | 0.16 | 1.37 | 2.15 | 2.25 |
| Depreciation | 0.19 | 0.39 | 0.65 | 0.65 |
| PBT | 0.72 | 1.15 | 3.14 | 6.06 |
| Tax % | 26.39% | 28.7% | 26.43% | 26.24% |
| Net Profit | 0.53 | 0.82 | 2.31 | 4.48 |
| EPS (₹) | 0.75 | 1.15 | 3.25 | 5.67 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Equity Capital | 2.85 | 2.85 | 2.85 | 3.15 |
| Reserves | 2.38 | 3.57 | 5.88 | 9.99 |
| Borrowings | 9.73 | 20.31 | 21.03 | 18.69 |
| Other Liabilities | 6.51 | 10.34 | 12.09 | 12.68 |
| Total Liabilities | 21.47 | 37.07 | 41.85 | 44.51 |
| Fixed Assets | 4.18 | 21.2 | 19.58 | 18.92 |
| CWIP | 8.57 | 0 | 0 | 0 |
| Investments | 0.02 | 0.02 | 0.02 | 0.02 |
| Other Assets | 8.7 | 15.85 | 22.25 | 25.57 |
| Total Assets | 21.47 | 37.07 | 41.85 | 44.51 |
Cash Flow
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating | 1.85 | −0.58 | 0.36 | 4.66 |
| Investing | −8.63 | −8.85 | 0.97 | 0 |
| Financing | 6.79 | 9.58 | −1.43 | −4.66 |
| Net Cash Flow | 0.01 | 0.15 | −0.11 | 0.01 |
| Free Cash Flow | −6.79 | −9.42 | 1.33 | 4.66 |
| CFO/EBITDA | 204 | −20 | 16 | 70 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Debtor Days | 94.02 | 93.27 | 73.76 | 94.43 |
| Inventory Days | 104 | 202 | 216 | 232 |
| Days Payable | 98.5 | 177 | 152 | 124 |
| Cash Conversion Cycle | 99.75 | 119 | 138 | 203 |
| Working Capital Days | −1.32 | −1.75 | −11.96 | 40.16 |
| ROCE % | — | 12.09% | 18.73% | 26.98% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Phytochem Remedies insights
29 extracted metrics across FY22–FY25.
Frequently Asked Questions about Phytochem Remedies (India)
What does Phytochem Remedies (India) Ltd do?
Company Information
Incorporated in 2002, Phytochem Remedies (India) Limited is a manufacturer of corrugated boxes and corrugated board solutions.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/1285830.md for Phytochem Remedies (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.